Fatigue in Sarcoidosis - Treatment With Methylphenidate
Status:
Unknown status
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
This is a small randomised-controlled trial (RCT) using methylphenidate as a treatment for
clinically-significant fatigue in sarcoidosis patients with stable disease. The primary
outcomes are feasibility, aimed at determining factors that will influence the design a
future, larger RCT, which will be powered to look at clinical efficacy of the intervention.
Phase:
N/A
Details
Lead Sponsor:
University of East Anglia
Collaborator:
Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)